Skip to main content

XCellR8 celebrates 10th year

6th November 2018

Submitted by:

Andrew Warmington

XCellR8, a north west, UK-based company that provides testing for the cosmetics industry, is celebrating its 10th year with a hat trick of growth news, including a new office move, new staff and funding.

The company provides entirely animal-free safety and efficacy tests to the cosmetics, personal care and chemical industries and is the only laboratory internationally to have achieved regulatory recognition for animal-free adaptations of regulatory tests that have not only eliminated the use of animals, but animal-derived components as well.

It is the only lab in the world to make its tests entirely animal-product free in a regulatory environment. It does not use serum, tissues or antibodies extracted from animals. Trusted by leading cosmetic and chemical companies around the world, it has just completed its 1,000th piece of testing for cosmetics giant Lush.

The company was founded in 2008 by Dr Carol Treasure and Bushra Sim and has a very clear mission to accelerate the world’s transition to animal-free testing. The 10th year sees it deliver a 37% year-on-year revenue growth following 40% growth in 2017.

The move to a new state-of-the-art laboratory on the National Science and Innovation Campus, SciTech Daresbury, will triple the company’s lab capacity expanding the R&D facilities while also growing the capacity for work with clients through the UK and internationally.

Growth for the company will be further accelerated with a £150k injection of funding from FW Capital, which has helped finance the move and will bring in new world-class lab equipment and additional work stations.

Dr Treasure said of the growth: “The past 10 years has seen myself and Bushra build the company that we dreamed of when we first became colleagues in 1996. From an early stage, we agreed that animal testing poses not only ethical issues but fundamental scientific ones. The world leading science we have developed within the business matched with our ethics and beliefs has meant that we have been able to grow a company based on our core values but firmly rooted in innovation and advancements in science.”

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington